270 related articles for article (PubMed ID: 29952102)
21. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
[TBL] [Abstract][Full Text] [Related]
22. Diffusion tensor imaging of vascular parkinsonism: structural changes in cerebral white matter and the association with clinical severity.
Wang HC; Hsu JL; Leemans A
Arch Neurol; 2012 Oct; 69(10):1340-8. PubMed ID: 22825428
[TBL] [Abstract][Full Text] [Related]
23. R2* relaxometry analysis for mapping of white matter alteration in Parkinson's disease with mild cognitive impairment.
Kan H; Uchida Y; Ueki Y; Arai N; Tsubokura S; Kunitomo H; Kasai H; Aoyama K; Matsukawa N; Shibamoto Y
Neuroimage Clin; 2022; 33():102938. PubMed ID: 34998126
[TBL] [Abstract][Full Text] [Related]
24. White matter damage and systemic inflammation in Parkinson's disease.
Chiang PL; Chen HL; Lu CH; Chen PC; Chen MH; Yang IH; Tsai NW; Lin WC
BMC Neurosci; 2017 Jun; 18(1):48. PubMed ID: 28595572
[TBL] [Abstract][Full Text] [Related]
25. Alteration of putaminal fractional anisotropy in Parkinson's disease: a longitudinal diffusion kurtosis imaging study.
Surova Y; Nilsson M; Lampinen B; Lätt J; Hall S; Widner H; van Westen D; Hansson O
Neuroradiology; 2018 Mar; 60(3):247-254. PubMed ID: 29368035
[TBL] [Abstract][Full Text] [Related]
26. Progressive microstructural alterations in subcortical nuclei in Parkinson's disease: A diffusion magnetic resonance imaging study.
Bai X; Zhou C; Guo T; Guan X; Wu J; Liu X; Gao T; Gu L; Xuan M; Gu Q; Huang P; Song Z; Yan Y; Pu J; Zhang B; Xu X; Zhang M
Parkinsonism Relat Disord; 2021 Jul; 88():82-89. PubMed ID: 34147950
[TBL] [Abstract][Full Text] [Related]
27. Regional Cerebral Disease Progression in Friedreich's Ataxia: A Longitudinal Diffusion Tensor Imaging Study.
Mascalchi M; Toschi N; Giannelli M; Ginestroni A; Della Nave R; Tessa C; Piacentini S; Dotti MT; Aiello M; Nicolai E; Soricelli A; Salvi F; Diciotti S
J Neuroimaging; 2016; 26(2):197-200. PubMed ID: 26175281
[TBL] [Abstract][Full Text] [Related]
28. Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson's disease.
Wen MC; Xu Z; Lu Z; Chan LL; Tan EK; Tan LCS
Sci Rep; 2017 Oct; 7(1):12559. PubMed ID: 28970540
[TBL] [Abstract][Full Text] [Related]
29. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
[TBL] [Abstract][Full Text] [Related]
30. Normal-appearing cerebral white matter in healthy adults: mean change over 2 years and individual differences in change.
Bender AR; Raz N
Neurobiol Aging; 2015 May; 36(5):1834-48. PubMed ID: 25771392
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal White Matter Damage Evolution in Parkinson's Disease.
Scamarcia PG; Agosta F; Spinelli EG; Basaia S; Stojković T; Stankovic I; Sarasso E; Canu E; Markovic V; Petrović I; Stefanova E; Pagani E; Kostic VS; Filippi M
Mov Disord; 2022 Feb; 37(2):315-324. PubMed ID: 34806799
[TBL] [Abstract][Full Text] [Related]
32. White matter integrity and cognition in Parkinson's disease: a cross-sectional study.
Auning E; Kjærvik VK; Selnes P; Aarsland D; Haram A; Bjørnerud A; Hessen E; Esnaashari A; Fladby T
BMJ Open; 2014 Jan; 4(1):e003976. PubMed ID: 24448846
[TBL] [Abstract][Full Text] [Related]
33. Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease.
Koinuma T; Hatano T; Kamagata K; Andica C; Mori A; Ogawa T; Takeshige-Amano H; Uchida W; Saiki S; Okuzumi A; Ueno SI; Oji Y; Saito Y; Hori M; Aoki S; Hattori N
J Parkinsons Dis; 2021; 11(3):1221-1235. PubMed ID: 33896850
[TBL] [Abstract][Full Text] [Related]
34. A test-retest study on Parkinson's PPMI dataset yields statistically significant white matter fascicles.
Cousineau M; Jodoin PM; Morency FC; Rozanski V; Grand'Maison M; Bedell BJ; Descoteaux M
Neuroimage Clin; 2017; 16():222-233. PubMed ID: 28794981
[TBL] [Abstract][Full Text] [Related]
35. Progression of microstructural damage in spinocerebellar ataxia type 2: a longitudinal DTI study.
Mascalchi M; Toschi N; Giannelli M; Ginestroni A; Della Nave R; Nicolai E; Bianchi A; Tessa C; Salvatore E; Aiello M; Soricelli A; Diciotti S
AJNR Am J Neuroradiol; 2015 Jun; 36(6):1096-101. PubMed ID: 25882284
[TBL] [Abstract][Full Text] [Related]
36. Microstructural changes in patients with Parkinson disease and REM sleep behavior disorder: depressive symptoms versus non-depressed.
Ghazi Sherbaf F; Rahmani F; Jooyandeh SM; Aarabi MH
Acta Neurol Belg; 2018 Sep; 118(3):415-421. PubMed ID: 29442234
[TBL] [Abstract][Full Text] [Related]
37. Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease.
Hope TR; Selnes P; Rektorová I; Anderkova L; Nemcova-Elfmarkova N; Balážová Z; Dale A; Bjørnerud A; Fladby T
PLoS One; 2019; 14(5):e0217922. PubMed ID: 31150514
[TBL] [Abstract][Full Text] [Related]
38. Free-Water Imaging in White and Gray Matter in Parkinson's Disease.
Andica C; Kamagata K; Hatano T; Saito A; Uchida W; Ogawa T; Takeshige-Amano H; Zalesky A; Wada A; Suzuki M; Hagiwara A; Irie R; Hori M; Kumamaru KK; Oyama G; Shimo Y; Umemura A; Pantelis C; Hattori N; Aoki S
Cells; 2019 Aug; 8(8):. PubMed ID: 31387313
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of diffusion and probabilistic white matter analysis in patients implanted with a deep brain stimulator.
Muller J; Alizadeh M; Li L; Thalheimer S; Matias C; Tantawi M; Miao J; Silverman M; Zhang V; Yun G; Romo V; Mohamed FB; Wu C
Neuroimage Clin; 2020; 25():102135. PubMed ID: 31901789
[TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
